Clinical trial

Longitudinal Study of Helium-3 and Xenon-129 Magnetic Resonance Imaging

NCT02279329

Study summary

ClinicalTrials.gov

Longitudinal Study of Helium-3 and Xenon-129 Magnetic Resonance Imaging

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention Hyperpolarized Helium MRI Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2009-05-01

PhaseNA

Conditions

COPDverified · MONDO: chronic obstructive pulmonary disease

Bronchiectasisverified · MONDO: bronchiectasis

Interventions

Hyperpolarized Helium MRIOTHER

Sponsors & collaborators

Dr. Grace Parragalead sponsor

London Health Sciences Centrecollaborator

Mapped research locations

LondonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02279329 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.